Viewing Study NCT05732103


Ignite Creation Date: 2025-12-24 @ 7:45 PM
Ignite Modification Date: 2026-01-02 @ 6:42 AM
Study NCT ID: NCT05732103
Status: RECRUITING
Last Update Posted: 2025-09-22
First Post: 2023-01-24
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of CTX-712 in Relapsed/Refractory Acute Myeloid Leukemia and Higher Risk Myelodysplastic Syndromes
Sponsor: Chordia Therapeutics, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module